Garnet E. Peck, PhD - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

KeywordLocation
About Search
Garnet E. Peck, PhD


Garnet E. Peck, PhD
Professor Emeritus of
Industrial Pharmacy
Purdue University

Garnet E. Peck is a professor emeritus and visiting professor in the department of industrial and physical pharmacy at Purdue University’s School of Pharmacy and Pharmaceutical Sciences. He received his BS (1957) in pharmacy from Ohio Northern University and MS (1959) and PhD (1962) degrees in industrial pharmacy from Purdue University. From 1962 to 1967, Peck was employed by the Mead Johnson Research Center and in 1967 he returned to Purdue University to join the department of industrial and physical pharmacy.  He was associate department head from 1989 to 1996.

Peck’s research interests include optimization of drug product design and process design, in particular those systems involving tablets, topical drug ad­sorption, flow of solid systems, dispersed systems design and evaluation, new tablet coating materials and procedures, and excipient-drug interaction. His research has resulted in more than 110 scientific publications.

Peck is a member of the APhA, the PT Section of the American Association of Pharmaceutical Scientists (AAPS), ACS, AACP, New York Academy of Science, Sigma Xi, Rho Chi, Phi Lambda Upsilon, Phi Kappa Phi and is a fellow of the AAAS, APRS, AAPS, and the American Institute of Chemists.  Peck was chairman of the IPT Section of the Academy of Pharmaceutical Sciences for 1983-84.  He was elected to the 1985-1990 United States Pharmacopeia Committee of Revision and then re-elected to the committee for 1990-1995 and 1995-2000. He was elected to the Committee of Experts, Excipients for 2000-2005. Peck is a founding member of The Catholic Academy of Science in the United States founded in 1987.

In March 1994, he was awarded by the American Pharmaceutical Association the Sidney L. Riegelman Research Achievement Award in Pharmaceutics, and he received the Pharmaceutical Technology Publishers’ Award in September 1994.

ADVERTISEMENT

post a comment
Your email address will NOT be published.
appears with your comment
read our privacy policy
Note: does not support HTML
All comments submitted are subject to review, and may be delayed before posting. We reserve the right not to post comments.
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What factor do you think will be most significant in 2010 for determining the health of the market for contract manufacturing of active pharmaceutical ingredients?
The global economic recovery
The US economic recovery
Improved credit and financing flow to the small to emerging pharma/bio sector
Less restrictive inventory control by pharmaceutical companies
The level of competition from contract manufacturers in emerging markets
The global economic recovery
40%
The US economic recovery
14%
Improved credit and financing flow to the small to emerging pharma/bio sector
14%
Less restrictive inventory control by pharmaceutical companies
9%
The level of competition from contract manufacturers in emerging markets
24%
View Results
Eric LangerOutsourcing OutlookEric Langer A Bio View of Outsourcing
Patricia Van ArnumIngredients InsiderPatricia Van Arnum Advances in Custom Synthesis
Faiz kermaniSpotlightFaiz Kermani EU pricing dilemmas
Faiz kermaniStatistical Solutions Lynn Torbeck%RSD: Friend or Foe?
Keep an eye on that cargo
Pharma packs a punch
Another Boost for Vaccines
Rodney Dangerfield and R&D
Federal Spending Freeze Could Threaten Supply-Chain Security
FindPharma Custom Search

Click here